‘Peacemaker’ immune cells could help treat diseases ranging from type 1 diabetes to neurodegeneration by restoring immune tolerance, according to a new Frontiers in Science lead article .
In their article, researchers Dr Jeffrey Bluestone , Nobel laureate Dr Frederick Ramsdell , Prof Megan Levings , and colleagues present a roadmap for developing Tregs as adaptable "living drugs" that can restore immune balance and support tissue repair.
Join these authors at our Frontiers in Science Deep Dive webinar on 30 September 2026, 16:00–17:30 CEST , as they explore how advances in cell engineering, delivery technologies, and patient selection could enable Treg therapies to be tailored to specific diseases, tissues, and immune environments, improving their ability to target the right immune responses in the right place, at the right time.
They will discuss how Treg cells can help repair tissues and maintain immune balance, opening new possibilities for treating conditions ranging from metabolic and cardiovascular disease to neurodegeneration.
Regulatory T cells: master orchestrators of immune tolerance and tissue homeostasis | 30 September 2026 | Register
Frontiers in Science Deep Dive sessions bring researchers, policy experts, and innovators together from around the world to discuss a specific area of transformational science published in Frontiers' flagship, multidisciplinary journal, Frontiers in Science, and explore next steps for the field.